MD-7246

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Irritable Bowel Syndrome With Diarrhea (IBS-D)

Drug Information

Target Indication

Irritable Bowel Syndrome With Diarrhea (IBS-D)

Clinical Trial

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

IRWD

IRONWOOD PHARMACEUTICALS INC

Related Pipeline

Gastroesophageal Reflux Disease (GERD)

Irritable Bowel Syndrome With Constipation

Irritable Bowel Syndrome With Constipation

Gastroesophageal Reflux Disease

Diabetic Gastroparesis

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts